AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 231 min read$DGX

Key facts: NYSE:DGX Q3 beat; cybersecurity incident; Apple Health kit

Quest Diagnostics (DGX) reported Q3 revenue of $3.10B, up 10% YoY, and adjusted EPS of $3.00, up 15%. The company raised its FY26 revenue and adjusted EPS guidance. DGX disclosed a cybersecurity incident, causing a share price drop. It plans to offer a lab test kit via Apple Health and has made strategic acquisitions and testing expansions.

Original reporting
tradingview.com
Published Oct 23, 2026, 7:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 7:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Key facts: NYSE:DGX Q3 beat; cybersecurity incident; Apple Health kit — source image
Source · tradingview.com
Decision brief

The 30-second read

$DGXNeutralHigh
01

Why it matters

Earnings beat and raised guidance suggest strong demand, while the cyber incident introduces risk. Investors must balance these factors.

02

Market read

The earnings beat and guidance raise are primary catalysts for DGX, with the cyber incident adding a short‑term risk factor.

03

What to watch

Potential regulatory scrutiny following the cyber breach and its effect on future contracts or partnerships.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Quest Diagnostics (NYSE:DGX) released its Q3 2026 earnings, announced a cybersecurity incident, and disclosed new product and acquisition initiatives.

Company-level read

Ticker impact

$DGXNeutralHigh confidence
Context

Quest Diagnostics reported Q3 revenue $3.10B (+10% YoY) beating estimates and raised FY26 revenue guidance to $12.065‑$12.105B.

Expected impact

mixed pressure as investors weigh strong earnings against cyber‑risk concerns

Evidence & confidence

Positive earnings and guidance typically lift the stock, while a cyber incident can trigger short‑term selling.

Market effects

Sector

Strong earnings may boost the broader healthcare diagnostics sector, but cyber‑risk concerns could heighten scrutiny of data security practices.

Regional

U.S. market focus on earnings and cyber‑security could influence peer labs and related service providers.

Global

Limited to U.S. diagnostics and cybersecurity discussions; no immediate global macro impact.

Counterpoint

What could challenge this read

The cyber incident could signal deeper operational vulnerabilities, outweighing the earnings beat and prompting a short‑term sell‑off.

Key entities

  • company
    Quest Diagnostics

    Provider of diagnostic testing services, ticker DGX.

Read at source← All news

Related articles

OCT 25
$DGXLow

Medical Testing Giant Quest Diagnostics Confirms Massive Security Breach Exposing Sensitive Patient Records Amid a Coordinated Global Hacking Surge

Quest Diagnostics confirmed a security breach exposing patient records via its Quanum Lab Services Manager system. The breach, discovered on October 21, impacted protected health information and personal data. The company has taken steps to contain the breach, but the full extent of the damage is still under investigation. This incident is part of a broader surge in global cyberattacks, including a critical flaw in the PHP programming language.

istitutoimpariamo.it3 min
OCT 24
$DGXMedAI 8/10

Quest Diagnostics Q3 2026 Revenue Rises to $3.1B, Diluted EPS Up to $2.78

Quest Diagnostics reported Q3 2026 revenue of $3.1B, up 10% YoY, with diluted EPS rising to $2.78. Operating income increased to $479M. Year-to-date revenue reached $9.035B, with net income attributable to Quest at $884M. The company maintained strong cash flow and returned capital through buybacks and dividends, but noted rising operating costs and debt.

minichart.com.sg2 min